^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Small Intestinal Carcinoma |
| Regimen: | CAPOX (capecitabine + oxaliplatin) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
...FOLFOX or CAPEOX are recommended as first-line therapy options for treatment of patients with advanced SBA who are appropriate for intensive therapy.
